Selectivity of 7-alkoxycoumarins as probe substrates for rat hepatic cytochrome P450 forms is influenced by the substitution pattern on the coumarin nucleus

Reference

• ABDOU, W. M., MAHRAN, M. R., MAHMOUD, M. and WAMHOFF, H., 1988, Photochemistry of pesticides. 13. Some photoreactions of 0,0-diethyl-0-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)phosphor-othioate (Potasan). Phosphorus and Sulfur, 39, 199–203.
   Web of Science ®Google Scholar
• AITIO, A., 1978, A simple and sensitive assay of 7-ethoxycoumarin deethylation. Analytical Biochemistry, 85, 488–491.
   PubMed Web of Science ®Google Scholar
• BALL, S. E., THIEL, V. E., TR), C. 0., Lim, H.-K., KAO, J., SISENWINE, S. F. and SCATINA, J., 1996, [14C]7-ethoxycoumarin metabolism in precision-cut rat hepatic slices. Drug Metabolism and Disposition, 24, 383–389.
   Google Scholar
• BOOBIS, A. R., KAHN, G. C., WHYTE, C., BRODIE, M. J. and DAVIES, D. S., 1981, Biphasic 0-deethylation of phenacetin and 7-ethoxycoumarin by human and rat liver microsomal fractions. Biochemical Pharmacology, 17, 2451–2456.
   Google Scholar
• CRESPI, C. L. and STRESSER, D. M., 2000, Fluorometric screening for metabolism-based drug—drug interactions. Journal of Pharmacological and Toxicological Methods, 44, 325–331.
   PubMed Web of Science ®Google Scholar
• DEAN, F. M. and PARTON, B., 1969, The structure and synthesis of (+)-obliquin. Journal of the Chemical Society C, 526–531.
   Google Scholar
• DELucA, J. G., DYSART, G. R., RASNICK, D. and BRADLEY, M. 0., 1988, A direct, highly sensitive assay for cytochrome P-450 catalyzed 0-deethylation using a novel coumarin analog. Biochemical Pharmacology, 37, 1731–1739.
   Google Scholar
• FERNYHOUGH, L., KELL, S. W., HAMMOND, A. H., THOMAS, N. W. and FRY, J. R., 1994, Comparison of in vivo and in vitro rat hepatic toxicity of coumarin and methyl analogues, and application of quantitative morphometry to toxicity in vivo. Toxicology, 88, 113–125.
   PubMedGoogle Scholar
• FRY, J. R., CARLE, M. J. and LAL, K., 1992, Differentiation of cytochrome P450 inducers on the basis of 7-alkoxycoumarin 0-dealkylase activities. Xenobiotica, 22, 211–215.
   PubMed Web of Science ®Google Scholar
• FUKUTO, J. M., KUMAGAI, Y. and CH0, A. K., 1991, Determination of the mechanism of demethylenation of (methylenedioxy)phenyl compounds by cytochrome P450 using deuterium isotope effects. Journal of Medicinal Chemistry, 34, 2871–2876.
   Google Scholar
• GIURNAZI, A. M., CARLE, M. J., LAL, K. and FRY, J. R., 1996, 7-Ethoxy-3,4-dimethylcoumarin: a substrate for a cytochrome P450-mediated mono-oxygenase activity that is highly induced by phenobarbitone and 0-naphthoflavone. Journal of Pharmacy and Pharmacology, 48, 729–733.
   PubMedGoogle Scholar
• HAMMOND, A. H. and FRY, J. R., 1997, Involvement of cytochrome P4502E1 in the toxicity of dichloropropanol to rat hepatocyte cultures. Toxicology, 118, 171–179.
   PubMed Web of Science ®Google Scholar
• INDAHL, S. R. and SCHELINE, R. R., 1971, The metabolism of umbelliferone and herniarin in rats and by the intestinal microflora. Xenobiotica, 1, 13–24.
   PubMedGoogle Scholar
• JUNG, B., GRAF, H. and ULLRICH, V., 1985, A new monooxygenase product from 7-ethoxycoumarin and its relation to the 0-dealkylation product. Bio-Chemische Hoppe-Seyler, 366, 23–31.
   PubMedGoogle Scholar
• KAMATAKI, T., ANDO, M., YAMAZOE, Y., Ism', K. and KATO, R., 1980, Sex difference in the 0-dealkylation activity of 7-hydroxycoumarin 0-alkyl derivatives in liver microsomes of rats. Biochemical Pharmacology, 29, 1015–1022.
   Google Scholar
• KNOEVENAGEL, E. and SCHRoTER, F., 1898, Ueber eine darstellungsweise der alkyliden-acetessigester. Bereich Deutsche Chemische Gesellschaft, 31, 730–737.
   Google Scholar
• LEWIS, D. F. V., 2000, On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics. Biochemical Pharmacology, 60, 293–306.
   PubMed Web of Science ®Google Scholar
• LEWIS, D. F. V., IOANNIDES, C. and PARKE, D. V., 1986, Molecular dimensions of the substrate binding site of cytochrome P-448. Biochemical Pharmacology, 35, 2179–2185.
   Google Scholar
• LEWIS, D. F. V. and LAKE, B. G., 1997, Molecular modelling of mammalian CYP2B isoforms and their interactions with substrates, inhibitors and redox partners. Xenobiotica, 27, 443–478.
   Google Scholar
• LIN J. H and Lu A. Y. H., 2001, Interindividual variability in inhibition and induction of cytochrome P450 enzymes. Annual Reviews of Pharmacology and Toxicology, 41, 535–567.
   Google Scholar
• Lu, A. Y. H., WANG, R. W. and LIN, J. H., 2003, Cytochrome P450 in vitro reaction phenotyping: a re-evaluation of approaches used for P450 isoform identification. Drug Metabolism and Disposition, 31, 345–350.
   Google Scholar
• MANN, F. G. and SAUNDERS, B. C., 1960, Practical Organic Chemistry, 4th edn (London: Longman), pp. 305–306.
   Google Scholar
• MATSUBARA, T., OTSUBO, S., YOSHIHARA, E. and TOUCHI, A., 1983, Biotransformation of coumarin derivatives (2) Oxidative metabolism of 7-alkoxycoumarins by microsomal enzymes and a simple assay procedure for 7-alkoxycoumarin 0-dealkylase. Japanese Journal of Pharmacology, 33, 41–56.
   PubMedGoogle Scholar
• NAKAMURA, K., HANNA, I. H., CAI, H., NISHIMURA, Y., WILLIAMS, K. M. and GUENGERICH, F. P., 2001, Coumarin substrates for cytochrome P450 2D6 fluorescence assays. Analytical Biochemistry, 292, 280–286.
   PubMed Web of Science ®Google Scholar
• OKUYUMA, M., INOUE, C., AIJIMA, K., NAKAMURA, Y., KABURAGI, T. and SHIGEMATSU, A., 1997, In vitro method for assessing hepatic drug metabolism. Biological and Pharmaceutical Bulletin, 20, 1–5.
   PubMedGoogle Scholar
• PATERSON, P., FRY, J. R. and HORNER, S. A., 1984, Influence of cytochrome P-450 type on the pattern of conjugation of 7-hydroxycoumarin generated from 7-alkoxycoumarins. Xenobiotica, 14, 849–859.
   PubMed Web of Science ®Google Scholar
• RAJANIBALA, K., PANDYA, K. and PANDYA, C., 1955, The condensation of aldehydes with b-oxo esters in the presence of organic bases. 1. Salicylaldehyde and its derivatives with ethyl acetoacetate. Agra University Journal of Research, 4, 305–315.
   Google Scholar
• RANGASWAMI, SESHADRI and VENKATEswARLu, 1941, Proceedings of the Indian Academy of Sciences Section A, 13, 316–318. [identified through the MDL Crossfire Beilstein Commander program]
   Google Scholar
• REEN, R. K., RAMAKANTH, S., WIEBEL, F. J., JAIN, M. P. and SINGH, J., 1991, Dealkylation of 7-methoxycoumarin as assay for measuring constitutive and phenobarbital-inducible cytochrome P450s. Analytical Biochemistry, 194, 243–249.
   PubMedGoogle Scholar
• RENWICK, A. B., LAVIGNETTER, G., WORBOYS, P. D., WILLIAMS, B., SURRY, D., LEWIS, D. F. V., PRICE, R. J., LAKE, B. G. and EVANS, D. C., 2001, Evaluation of 7-benzyloxy-4-trifluoro-methylcoumarin, some other 7-hydroxy-4-trofluoromethylcoumarin derivatives as fluorescent derivatives as fluorescent substrates for rat hepatic cytochrome P450 enzymes. Xenobiotica, 31, 861–878.
   Google Scholar
• ROSER, R. and THOMAS, H., 2000, A direct, highly sensitive fluorometric assay for a microsomal cytochrome P450-mediated 0-demethylation using a novel coumarin analog substrate. Zeitscrift far Naturforschung C, 55, 915–922.
   PubMedGoogle Scholar
• SHAH, D. N. and SHAH, N. M., 1954, The Fries isomerization of acetyl and benzoyl esters of umbelliferones. Journal of Organic Chemistry, 19, 1681–1685.
   Google Scholar
• SHARMA, U., ROBERTS, E. S. and HOLLENBERG, P. F., 1996, Inactivation of cytochrome P4502B1 by the monoamine oxidase inhibitors R-(—)-deprenyl and clorgyline. Drug Metabolism and Disposition, 24, 669–675.
   PubMed Web of Science ®Google Scholar
• THAKOR and SHAH, 1947, Journal of University of Bombay Science, 15/5A, 14. [identified through the MDL Crossfire Beilstein Commander program]
   Google Scholar
• TSUJIHARA, K., HONGU, M., SAITO, K., KAWANISHI, H., KURIYAMA, K., MATSUMOTO, M., OKU, A., UETA, K., TSUDA, M. and SAITO, A., 1999, Natglucose cotransporter (SGLT) inhibitors as antidiabetic agents. 4. Synthesis and pharmacological properties of 4'-dehydroxyphlorizin derivatives substituted on the B ring. Journal of Medicinal Chemistry, 42, 5311–5324.
   PubMed Web of Science ®Google Scholar
• ULLRICH, V., FROMMER, U. and WEBER, P., 1973, Differenceas in the 0-dealkylation of 7-ethoxycoumarin after pretreatment with phenobarbital and 3-methylcholanthrene. Hoppe-Seyler Zeitschrift far Physiologische Chemie, 354, 514–520.
   PubMedGoogle Scholar
• ULLRICH, V. and WEBER, P., 1972, The 0-dealkylation of 7-ethoxycoumarin by liver microsomes. Hoppe-Seyler Zeitschrift far Physiologische Chemie, 353, 1171–1177.
   PubMedGoogle Scholar
• USGAONKAR, R. N., THAKOR, V. M. and JADHAv, G. V., 1953, Pechmann condensation. I. Condensation of 2,5-disubstituted phenols with ethyl acetoacetate. Journal of the Indian Chemical Society, 30, 535–538.
   Google Scholar
• WALSH, J. S. and MIWA, G. T., 1984, The mechanism of the cytochrome P448-mediated 6-hydroxylation of 7-ethoxycoumarin. Biochemical and Biophysical Research Communications, 121, 960–966.
   PubMedGoogle Scholar
• WHITE, I. N. H., 1988, A continuous fluorometric assay for cytochrome P-450-dependent mixed function oxidases using 3-cyano-7-ethoxycoumarin. Analytical Biochemistry, 172, 304–310.
   PubMed Web of Science ®Google Scholar
• YUAN, R., MADANI, S., WET, X.-X., REYNOLDS, K. and HUANG, S.-M., 2002, Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions. Drug Metabolism and Disposition, 30, 1311–1139.
   Google Scholar